I agree kbear, my gut feel is that they know the ICS data is good and that we are going to be opened up to other cancer markets. I also think that the phase 11b data is probably too early in the trials to provide any really meaningful data re: efficacy
With the potential for treating other cancers, the target market is gigantic, and I'm now starting to feel that takeover interest from big pharma is not far away
I agree kbear, my gut feel is that they know the ICS data is...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.5¢ | 33.5¢ | $178.8K | 528.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 142082 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 13437 | 7 |
View Market Depth
| Last trade - 12.20pm 31/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |